Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/13/2024
Recent Executive Moves
12/12/2024
Shanghai Unveils RMB10 Billion Biopharma M&A Fund to Drive Industry Gr...
12/12/2024
Bayer Co.Lab Expands in China with Three New Biotech Partners
12/12/2024
Chinese Generic Drug Market Expected to Rise at 10.70% CAGR During 202...
12/12/2024
JPO Publicizes the Proposed Results of the 10th National VBP
12/11/2024
South China Public Hospitals Slash Salaries Amid Mounting Financial Pr...
12/11/2024
Santhera Wins First Chinese Approval for Duchenne Muscular Dystrophy ...
12/10/2024
The Proposed BIOSECURE Act Faces Setback in Senate
12/10/2024
NHSA and NHC Jointly Issue New Policy Document on Centralized Drug Pro...
12/10/2024
Abbisko Reports Promising Preliminary Phase 2 Data for Pimicotinib in ...
12/10/2024
Loncastuximab Tesirine Gains Approval in China for 3L r/r DLBCL Treatm...
12/10/2024
Merck's Keytruda Gains First Approval in China for Cervical Cancer Tre...
12/10/2024
Sperogenix's Vamorolone Approved in China for DMD
12/10/2024
China Biopharma CDMOs Win Reprieve as Biosecure Act Omitted from US De...
12/10/2024
Beijing Hanmi Launches $98.65M Expansion Project Near Capital Airport
12/10/2024
China Biopharma Tracker – November 2024 (PharmaDJ)
12/10/2024
How Wholly Foreign-Owned Hospitals Can Help China's Health Care Sector...
12/10/2024
The New Draft Administrative Measures For Management Of Medical Repres...
12/9/2024
Belief Biomed Unveils Promising Gene Therapy Data at ASH 2024
12/6/2024
Medical Costs in Mainland China and Hong Kong to Grow More Slowly Than...
12/6/2024
CDE Seeks Comments on Draft ICH Guidelines M15
12/6/2024
Recent Executive Moves
12/5/2024
SK Biopharm Advances Epilepsy Treatment in China with NDA Submission ...
12/5/2024
2025 Trends Buoying Boom Phase in APAC (Biospectrum)
12/5/2024
Big Pharma Doubles Down on China (The Wire China)
12/3/2024
Big Pharma's Bet on China Biotech Is a Rare Trade Bright Spot (Bloomb...
12/3/2024
CMS Gains Licenses Class 1 New Drug Targeting Gout and Hyperuricemia f...
12/3/2024
Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...
12/3/2024
NHC Minister Meets with Sanofi and BioMérieux Bosses to Strengthen Si...
12/3/2024
PharmaMar/Luye's Lurbinectedin Gains Approval in China for Treating Me...
Page:
13
/
356
Total number of articles:
10656
:
[First]
[<<]
[11]
[12]
[13]
[14]
[15]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit